ETF Holdings Breakdown of SNDX

News associated with SNDX

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $35.91 Average PT from Analysts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has earned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year price […] - 2025-06-24 05:36:53

ProShare Advisors LLC Has $359,000 Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

ProShare Advisors LLC grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 32.2% during the fourth quarter, Holdings Channel reports. The firm owned 27,183 shares of the company’s stock after acquiring an additional 6,627 shares during the quarter. ProShare Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $359,000 at the end of […] - 2025-05-29 08:04:57

Millennium Management LLC Sells 533,153 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Millennium Management LLC trimmed its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 47.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 586,810 shares of the company’s stock after selling 533,153 shares during the quarter. Millennium Management LLC’s holdings in Syndax Pharmaceuticals were worth $7,758,000 at the end of the most recent […] - 2025-05-27 07:54:51

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. […] - 2025-05-27 05:49:01

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC reduced its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 89.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 20,657 shares of the company’s stock after selling 166,806 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $273,000 as of its most recent […] - 2025-05-13 09:15:02

Dimensional Fund Advisors LP Has $4.38 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Dimensional Fund Advisors LP increased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 594.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 331,300 shares of the company’s stock after buying an additional 283,577 shares during the […] - 2025-05-13 07:38:47

Marshall Wace LLP Decreases Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Marshall Wace LLP lessened its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 98.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,624 shares of the company’s stock after selling 977,280 shares during the period. Marshall Wace LLP’s holdings in Syndax […] - 2025-05-06 07:44:58

Tower Research Capital LLC TRC Has $240,000 Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Tower Research Capital LLC TRC boosted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 179.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,190 shares of the company’s stock after purchasing an additional 11,681 shares during the period. Tower […] - 2025-05-05 08:30:49

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.20 Consensus Price Target from Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price […] - 2025-05-05 05:49:06

Geode Capital Management LLC Sells 3,966 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Geode Capital Management LLC trimmed its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 0.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,973,116 shares of the company’s stock after selling 3,966 shares during the period. […] - 2025-04-18 07:34:51

KLP Kapitalforvaltning AS Invests $219,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

KLP Kapitalforvaltning AS acquired a new stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 16,600 shares of the company’s stock, valued at approximately $219,000. Other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd acquired a new […] - 2025-04-08 08:04:47

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Acquired by Teacher Retirement System of Texas

Teacher Retirement System of Texas lifted its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 18.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 22,769 shares of the company’s stock after purchasing an additional 3,585 shares during the period. Teacher Retirement System of Texas’ holdings in Syndax Pharmaceuticals were worth $301,000 […] - 2025-04-02 07:42:46

Signaturefd LLC Cuts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Signaturefd LLC lessened its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 45.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,078 shares of the company’s stock after selling 1,745 shares during the quarter. Signaturefd LLC’s holdings in Syndax Pharmaceuticals were worth $27,000 as of […] - 2025-03-26 07:48:52

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.5% on Analyst Upgrade

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) shares shot up 5.5% on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $39.00 to $41.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Syndax Pharmaceuticals traded as high as $13.51 and last traded at $13.84. 164,424 […] - 2025-03-21 05:42:50

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.4% on Disappointing Earnings

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) were down 7.4% during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $14.23 and last traded at $14.34. Approximately 1,069,083 shares were traded during trading, a decline of 53% from the average daily volume of 2,257,449 shares. […] - 2025-03-06 08:13:39

Citigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $42.00

Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price target reduced by Citigroup from $45.00 to $42.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Other research analysts also recently issued reports about the company. The Goldman Sachs Group lifted their target price […] - 2025-03-05 08:45:05

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC lowered its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 18.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,178 shares of the company’s stock after selling 5,750 shares during the quarter. Sanctuary Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $358,000 at the end of the most […] - 2025-03-04 08:20:47

Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Price Target at $36.20

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12-month price objective among […] - 2025-02-19 06:30:59

1,940 Shares in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Acquired by R Squared Ltd

R Squared Ltd purchased a new stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,940 shares of the company’s stock, valued at approximately $26,000. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. […] - 2025-02-05 08:42:48

SNDX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	51,863	USD 482,326
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	48,839	USD 454,203
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	43,474	USD 404,308
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	43,474	USD 404,308
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,598	USD 14,861
Total =		189,248	USD 1,760,006

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer